If you live in the New York area, mark your calendar! This September 17, 2017 at 9 am, join our community member and fundraiser Erica…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
The National Comprehensive Cancer Network® (NCCN®) recently updated their treatment guidelines for malignant pleural mesothelioma. The NCCN, a not-for-profit alliance of 27 leading cancer centers devoted…
“I spent 20 years trying to do immunotherapy and we weren’t as successful as we wanted to be probably because we didn’t recognize the degree…
At the end of October of 2017, Dr. H. Richard Alexander, esteemed surgeon specializing in peritoneal mesothelioma, will be moving from his current institution, the…
In a statement released on Sunday, Bayer announced that Anetumab ravtansine, its antibody-drug conjugate (ADC) tested in mesothelioma, has missed its primary endpoint failing to…
Mesothelioma researcher and Meso Foundation grant recipient Prasad S. Adusumilli, MD, FACS, FCCP, of the Memorial Sloan Kettering Cancer Center (MSKCC) was an author on…
Joseph R. Testa, PhD, of the Fox Chase Cancer Center has edited a newly published book titled “Asbestos and Mesothelioma” to serve as a resource…
In 2015, data was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting from a Phase III French study that demonstrated improved survival…
The April 2017 issue of Translational Lung Cancer Research features an article titled Immunotherapy and radiation therapy for malignant pleural mesothelioma written by a group…
Michele Carbone, MD, PhD, Director of Thoracic Oncology at the University of Hawaii (UH) Cancer Center, along with his team, have discovered why people carrying…
